Saltar ao contenido
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avanzado
  • PHASE I TRIAL OF A HIGHLY IMMU...
  • Citar
  • Text this
  • Enviar este rexistro por email
  • Imprimir
  • Exportar rexistro
    • Exportar a RefWorks
    • Exportar a EndNoteWeb
    • Exportar a EndNote
  • Permanent link
PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES

Show other versions (1)
Detalles Bibliográficos
Main Authors: Folgori, A, Barnes, E, Aston, S, Smith, K, Brown, A, Ambrosio, M, Ammendola, V, Bartiromo, M, Capone, S, Naddeo, M, Sparacino, A, Siani, L, Traboni, C, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P
Formato: Conference item
Publicado: 2009
  • Existencias
  • Descripción
  • Other Versions (1)
  • Títulos similares
  • Staff View
Mostrando 1 - 1 Resultados de 1
Show all versions (2)
Search Result 1
PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES por Barnes, E, Antonella, F, Aston, S, Smith, K, Brown, A, Capone, S, Ambrosio, M, Harrison, G, Ammendola, V, Bartiromo, M, Traboni, C, Siani, L, Sparacino, A, Naddeo, M, Colloca, S, Cortese, R, Nicosia, A, Klenerman, P

Publicado 2009
Conference item
Show all versions (2)

Títulos similares

  • PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
    por: Barnes, E, et al.
    Publicado: (2009)
  • PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
    por: Barnes, E, et al.
    Publicado: (2011)
  • A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
    por: Kelly, C, et al.
    Publicado: (2011)
  • Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
    por: Capone, S, et al.
    Publicado: (2010)
  • Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.
    por: Capone, S, et al.
    Publicado: (2010)

Opciones de procura

  • Historial de Procuras
  • Procura avanzada

Buscar Máis

  • Revisar o catálogo
  • Lista alfabética
  • Explore Channels
  • Reservas de curso
  • Novos exemplares

Necesita Axuda?

  • Consello de procura
  • Consulte a un Bibliotecario
  • Preguntas Frecuentes